As of 2025-07-15, the Relative Valuation of Samjin Pharmaceutical Co Ltd (005500.KS) is 45,451.14 KRW. This relative valuation is based on P/E multiples. With the latest stock price at 20,300.00 KRW, the upside of Samjin Pharmaceutical Co Ltd based on Relative Valuation is 123.9%.
The range of the Relative Valuation is 22,784.68 - 87,397.12 KRW.
| Range | Selected | |
| Trailing P/E multiples | 9.5x - 30.5x | 19.5x |
| Forward P/E multiples | 8.1x - 19.1x | 12.5x |
| Fair Price | 22,784.68 - 87,397.12 | 45,451.14 |
| Upside | 12.2% - 330.5% | 123.9% |
| Date | P/E |
| 2025-05-12 | 6.24 |
| 2025-05-09 | 6.20 |
| 2025-05-08 | 6.19 |
| 2025-05-07 | 6.20 |
| 2025-05-02 | 6.16 |
| 2025-04-30 | 6.22 |
| 2025-04-29 | 6.22 |
| 2025-04-28 | 6.19 |
| 2025-04-25 | 6.21 |
| 2025-04-24 | 6.19 |
| 2025-04-23 | 6.18 |
| 2025-04-22 | 6.19 |
| 2025-04-21 | 6.18 |
| 2025-04-18 | 6.15 |
| 2025-04-17 | 6.13 |
| 2025-04-16 | 6.09 |
| 2025-04-15 | 6.09 |
| 2025-04-14 | 6.04 |
| 2025-04-11 | 6.00 |
| 2025-04-10 | 6.03 |
| 2025-04-09 | 5.82 |
| 2025-04-08 | 5.89 |
| 2025-04-07 | 5.89 |
| 2025-04-04 | 6.05 |
| 2025-04-03 | 6.04 |
| 2025-04-02 | 6.10 |
| 2025-04-01 | 6.12 |
| 2025-03-31 | 6.15 |
| 2025-03-28 | 6.21 |
| 2025-03-27 | 6.21 |
| 2025-03-26 | 6.19 |
| 2025-03-25 | 6.19 |
| 2025-03-24 | 6.17 |
| 2025-03-21 | 6.17 |
| 2025-03-20 | 6.21 |
| 2025-03-19 | 6.20 |
| 2025-03-18 | 6.25 |
| 2025-03-17 | 6.21 |
| 2025-03-14 | 6.16 |
| 2025-03-13 | 6.18 |
| 2025-03-12 | 6.31 |
| 2025-03-11 | 6.23 |
| 2025-03-10 | 6.25 |
| 2025-03-07 | 6.26 |
| 2025-03-06 | 6.29 |
| 2025-03-05 | 6.20 |
| 2025-03-04 | 6.13 |
| 2025-02-28 | 6.10 |
| 2025-02-27 | 6.24 |
| 2025-02-26 | 6.23 |